NovoCure Price Chart
NovoCure Volume Chart
NovoCure Market Segments
Regular Trading Hours
| Open | $15.87 |
|---|---|
| Close | $16.85 |
| Low | $15.61 |
| Low Change | -0.26 (-1.64%) |
| High | $17.31 |
| High Change | +1.44 (+9.07%) |
| Range | $1.70 |
| Volume | 1.278M |
| Dollar Volume | $21.53M |
Premarket
| Open | $15.78 |
|---|---|
| Close | $15.79 |
| Low | $15.75 |
| Low Change | -0.03 (-0.19%) |
| High | $15.79 |
| High Change | +0.01 (+0.06%) |
| Range | $0.04 |
| Volume | 1.734K |
| Dollar Volume | $27.38K |
Overnight
*No Trades in Segment
After Hours Yesterday
| Open | $15.78 |
|---|---|
| Close | $15.78 |
| Low | $15.47 |
| Low Change | -0.31 (-1.96%) |
| High | $15.96 |
| High Change | +0.18 (+1.14%) |
| Range | $0.49 |
| Volume | 287.103K |
| Dollar Volume | $4.53M |
Regular Trading Hours Yesterday
| Open | $15.39 |
|---|---|
| Close | $15.79 |
| Low | $15.29 |
| Low Change | -0.10 (-0.65%) |
| High | $16.00 |
| High Change | +0.61 (+3.96%) |
| Range | $0.71 |
| Volume | 938.799K |
| Dollar Volume | $14.82M |
Premarket Yesterday
| Open | $15.25 |
|---|---|
| Close | $15.15 |
| Low | $15.03 |
| Low Change | -0.22 (-1.44%) |
| High | $15.25 |
| High Change | +0.00 (+0.00%) |
| Range | $0.22 |
| Volume | 2.6K |
| Dollar Volume | $39.39K |
NovoCure News
2 weeks agoinvesting.comFreeCast surges premarket; Accenture, Novocure slide
- 2 weeks agoinvesting.com
Why is Novocure stock plummeting today?
- 2 weeks agoinvesting.com
Novocure stock tumbles after trial misses primary endpoint
- 3 months agoinvesting.com
Novocure stock rises on positive pancreatic cancer trial data
- 4 months agoinvesting.com
Novocure stock jumps after Medicare billing restored
5 months agobenzinga.comStock Market Today: Dow Jones, S&P 500 Futures Gain After Strong Job Report—Micron, Novocure, Fastly In Focus
- 5 months agoinvesting.com
Novocure shares surge after FDA approves pancreatic cancer device
- 5 months agobenzinga.com
NovoCure (NVCR) Stock Is Trending Overnight — Here's What You Should Know
- 5 months agoinvesting.com
Novocure shares soar 30% after FDA nod for pancreatic cancer device
- 5 months agoinvesting.com
Novocure stock falls after CMS revokes billing privileges
NovoCure Top Trades
NovoCure's top trade so far today returned +9.90%, while the top short trade returned -2.66%.
NovoCure Moving Averages
| 5 Day Moving Average (SMA5) | $15.38 |
|---|---|
| 10 Day Moving Average (SMA10) | $15.14 |
| 20 Day Moving Average (SMA20) | $16.20 |
| 50 Day Moving Average (SMA50) | $16.14 |
| 100 Day Moving Average (SMA100) | $13.98 |
| 200 Day Moving Average (SMA200) | $13.44 |
NovoCure Statistics
| Average Volume (30 Days) | 1.65M |
|---|---|
| P/E Ratio (Current) | -10.17 |
| EPS (Current) | -$1.49 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$48.07M |
| Cash Ratio | 0.40 |
| Current Ratio | 2.86 |
| Quick Ratio | 2.66 |
| Debt to Equity | 0.59 |
| Enterprise Value | $1.86B |
| EV to EBITDA | -11.09 |
| EV to Sales | 2.76 |
| Price to Book | 5.31 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 2.60 |
| Return on Assets | -0.22% |
| Return on Equity | -0.52% |
NovoCure Stock Splits
There have been no stock splits for NovoCure (NVCR).
NovoCure Dividends
There have been no dividends for NovoCure (NVCR).